Inhaled and intravenous treatment in acute severe and life-threatening asthma

British Journal of Anaesthesia

Volumn 110, Issue 2, 2013, Pages 183-190

  Sellers, W F S ^a  

^a STOKE MANDEVILLE HOSPITAL   (United Kingdom)

Author keywords

asthma; bronchospasm; inhaled anaesthetics; life threatening

Indexed keywords

ADRENALIN; AMINOPHYLLINE; BECLOMETASONE; DESFLURANE; HALOTHANE; HYDROCORTISONE; IPRATROPIUM BROMIDE; ISOFLURANE; KETAMINE; LIDOCAINE; MAGNESIUM; MAGNESIUM SULFATE; MONTELUKAST; NORFLURANE; PROPOFOL; RITODRINE; SALBUTAMOL; SEVOFLURANE; TERBUTALINE;

ANESTHESIA INDUCTION; APPARENT LIFE THREATENING EVENT; ARTICLE; ASSISTED VENTILATION; ASTHMA; BRONCHODILATATION; CALCIUM BLOOD LEVEL; DETERIORATION; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; ECLAMPSIA; ENDOTRACHEAL INTUBATION; EXPIRATORY RESERVE VOLUME; FORCED EXPIRATORY VOLUME; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HUMAN; INHALATION ANESTHESIA; INTUBATION; LOADING DRUG DOSE; MATERNAL HYPERTENSION; METERED DOSE INHALER; NEBULIZATION; NEBULIZER; OXYGEN TRANSPORT; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT; ST SEGMENT DEPRESSION; TACHYCARDIA; THORAX PAIN; THORAX PRESSURE; TOCOLYSIS; VOMITING;

EID: 84872735730     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes444     Document Type: Review

References (70)

1. Williams TJ, Tuxen DV, Sceinkestel CD, Czarny D, Bowes G. Risk factors for morbidity in mechanically ventilated patients with acute severe asthma. Am Rev Respir Dis 1992; 146: 607-15
2. British guidelines on the management of asthma. Thorax 2008; 63(Suppl. IV): Iv1-21. Revised Jan 2012
3. Guidelines on the diagnosis and management of asthma (EPR-3). National Institutes of Health (USA), 2007; section 5, managing exacerbations of asthma. Publication No. 07-4051
4. National Asthma Council Australia. Asthma Management Handbook 2006. Melbourne: National Asthma Council Australia, 2006
5. Newman SP. Principles of metered-dose inhaler design. Respir Care 2005; 50: 1177-88 (Pubitemid 46173332)
6. Respiratory system resistance. In: Lumb AB, ed. Nunn's Applied Respiratory Physiology, Chapter 4. Edinburgh: Churchill Livingstone Elsevier, 2010; 43-59
7. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone. Chest 2002; 122: 510-6 (Pubitemid 35002128)
8. O'Driscoll BR, Taylor RJ, Horsley MG, et al. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 1989; 1: 1418-20 (Pubitemid 19150046)
9. Penna AC, Dawson KP, Mangllick P, et al. Systemic absorption of salbutamol following nebuliser delivery in acute asthma. Acta Paediatr 1993; 82: 963-6 (Pubitemid 23348105)
10. Boe J, Dennis JH, O'Driscoll BR. European respiratory society guidelines on the use of nebulisers. Eur Respir J 2001; 18: 228-42 (Pubitemid 32717452)
11. Asmundsson T, Johnson RF, Kilburn KH, Goodrich JK. Efficiency of nebulisers for depositing saline in human lung. Am Rev Respir Dis 1973; 108: 506-12
12. Lewis RA, Flemming JS. Fractional deposition from a jet nebuliser: How it differs from a metered dose inhaler. Br J Dis Chest 1985; 79: 361-7 (Pubitemid 15229627)
13. Everard ML. Studies using radiolabelled aerosols in children. Thorax 1994; 49: 1259-66
14. Newman SP, Pellow PGD, Clark SW. Droplet size distributions of nebulised aerosols for inhalational therapy. Phys Physiol Meas 1986; 7: 139-46 (Pubitemid 16017978)
15. Emerman CL, Cydulka RK, McFadden ER. Comparison of 2.5 vs 7.5 mg of inhaled albuterol in the treatment of acute asthma. Chest 1999; 115: 92-6 (Pubitemid 29047058)
16. Rothenberg M. The breath-Stream dynamics of simple-releasedplosive production. Bibliotheca Phonetica VI. Basel: Karger, 1968
17. The Borg. Resistance is futile. Star Trek: First Contact (Film) 1996
18. Hogg J. The pathology of asthma. Clin Chest Med 1984; 5: 567-71 (Pubitemid 15159980)
19. Padkin AJ, Baigel G, Morgan GA. Halothane treatment of severe asthma to avoid mechanical ventilation. Anaesthesia 1997; 52: 994-7 (Pubitemid 27455516)
20. Sellers WFS. Pre-oxygenation with halothane in asthma. Anaesth Intensive Care 1991; 19: 478
21. Advanced Paediatric Life Support, 2005; 85
22. Rooke GA, Choi JH, Bishop MJ. The effect of isoflurane, halothane, sevoflurane and thiopental/nitrous oxide on respiratory system resistance after tracheal intubation. Anesthesiology 1997; 86: 1294-99 (Pubitemid 27262306)
23. Functional anatomy of the respiratory tract. In: Lumb AB, ed. Nunn's Applied Respiratory Physiology. Edinburgh: Churchill Livingstone Elsevier, 2010; 13-26
24. Gourgoulianis KI, Chatziparasidis G, Chatziefthimiou A, Molyvdas PA. Magnesium as a relaxing factor of airway smooth muscles. J Aerosol Med 2011; 14: 301-7
25. Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA. Magnesium sulphate for treating exacerbations of acute asthma in the emergency department (Cochrane Review). The Cochrane Library, 2003. Oxford: Update Software
26. Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Archiv Paediatric Adolesc Med 2000; 154: 979-83
27. Jones LA, Goodacre S. Magnesium sulphate in the treatment of acute asthma: Evaluation of current practice in adult emergency departments. Emerg Med J 2009; 26: 783-5
28. Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases. Am J Obstet Gynecol 1984; 148: 951-63 (Pubitemid 14125713)
29. Cotton DB, Gonik B, Dorman KF. Cardiovascular alterations in severe pregnancy-induced hypertension: Acute effects of intravenous magnesium sulphate. Am J Obstet Gynecol 1984; 148: 162-5 (Pubitemid 14224251)
30. Mroczek WJ, Lee WR, Davidov ME. Effect of magnesium sulfate on cardiovascular hemodynamics. Angiology 1977; 28: 720-4 (Pubitemid 8212213)
31. Piotrowski AA, Kalus JS. Magnesium for treatment and prevention of atrial tachyarrhythmias. Pharmacotherapy 2004; 24: 879-95 (Pubitemid 38864776)
32. Chandraharan E, Arulkumaran S. Acute tocolysis. Curr Opin Obstet Gynecol 2005; 17: 151-6 (Pubitemid 40432736)
33. Ferguson JE, Hensleigh PA, Kredenster D. Adjunctive use of magnesium sulphate with ritodrine for preterm labor tocolysis. Am J Obstet Gynecol 1984; 148: 166-70
34. Ramussen HS, Thomsen PEB. The electrophysiologic effects of intravenous magnesium on human sinus node, atrium and ventricle. Clin Cardiol 1989; 21: 85-90 (Pubitemid 19057508)
35. White RE, Hartzell HC. Magnesium ions in cardiac function. Biochem Pharmacol 1989; 38: 859-67
36. Sellers WFS. Intravenous magnesium and salbutamol for asthma. Anaesthesia 2004; 59: 198
37. Sellers WFS, Ahmad I, Bathke PSJ, Brown CJ, Fernandez T, Barker A. Intravenous magnesium sulphate prevents intravenous salbutamol tachycardia in asthma. Br J Anaesth 2010; 105: 869-70
38. Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA Jr, Rowe BH. Intravenous beta 2 agonists for acute asthma in the emergency department (Cochrane Review). The Cochrane Library, 2003. Oxford: Update Software
39. Beveridge RC, Grunfeld AF, Hodder RV, Verbeek PR. Guidelines for the emergency management of asthma in adults. Can Med Assoc Jl 1996; 155: 25-37 (Pubitemid 26235402)
40. Salmeron S, Brochard L, Mal H, Tenaillon A, et al. Nebulised versus albuterol in hypercapnic acute asthma. Am J Respir Crit Care Med 1994; 149: 1466-70
41. Browne GJ, Penna AS, Phung X, Soo M. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet 1997; 349: 301-5 (Pubitemid 27056820)
42. Sellers WFS, Messahel B. Rapidly repeated intravenous boluses of salbutamol for acute severe asthma. Anaesthesia 2003; 58: 680-4
43. Browne GJ, Wilkins BH. Editorial. Use of intravenous salbutamol in acute severe asthma. Anaesthesia 2003; 58: 729-32 (Pubitemid 36934562)
44. Bohn D, Kalloghlian A, Henkins J, Barker G. Intravenous salbutamol in the treatment of status asthmaticus in children. Crit Care Med 1984; 12: 829-36
45. Beta 2 agonists, ritodrine hydrochloride. British National Formulary 2010; 7.1.3: 47
46. Dempsey OJ. Leukotriene receptor agonist therapy. Postgrad Med J 2000; 76: 767-73
47. Camargo CA Jr, Smithline HA, Malice MP, Green SA, Reiss TF A randomised controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003; 167: 528-33
48. Yung M, South M. Randomised trial of aminophylline for acute severe asthma. Archiv Dis Childhood 1998; 79: 405-10 (Pubitemid 28495997)
49. Ram FS, Wellington S, Rowe BH, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2005; CD004360
50. Brown RH, Wagner EM. Mechanisms of bronchoprotection by anaesthetic induction agents: Propofol versus ketamine. Anesthesiology 1999; 90: 822-8 (Pubitemid 29113703)
51. Howton JC, Rose J, Duffy S, Zoltanski T, Levitt MA. Randomised, double blind, placebo-Controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med 1996; 27: 170-5 (Pubitemid 26055077)
52. Fisher MM, Bowey CJ, Ladd-Hudson K. External chest compression in acute asthma: A preliminary study. Crit Care Med 1989; 17: 686-7
53. Harrison R. Chest compression first aid for respiratory arrest due to acute asphyxic asthma. Emerg Med J 2010; 27: 59-60
54. Levy BD, Kitch B, Fanta CH. Medical and ventilatory management of status asthmaticus. Intensive Care Med 1998; 24: 105-17 (Pubitemid 28192090)
55. Kusurkar A I, Macartney NJD II, Hingston CD, Holmes TN, Wise MP III, Walker A IV. Airway emergency during anaesthesia using a metered-dose inhaler. Anaesthesia 2011; 66: 530-1
56. Elliot S, Berridge JC, Mallick A. Use of the AnaConDa anaesthetic delivery system in ICU. Anaesthesia 2007; 62: 752-3
57. Asthma UK. Key facts and statistics, 2011. Available from www. asthma.org.uk
58. Wasserfallen JB, Schaller MD, Feihl F, Perret CH. Sudden asphyxic asthma: A distinct entity? Am Rev Respir Dis 1990; 142: 108-11 (Pubitemid 20224587)
59. Saving Mothers' Lives. Br J Obstet Gynaecol 2011; 118: 1-203
60. Rey E, Boulet L-P. Asthma in pregnancy. Br Med J 2007; 334: 582-4
61. Krishnan V, Diette GB, Rand CS, et al. Mortality in patients hospitalised for asthma exacerbations in the United States. Am J Respir Crit Care Med 2006; 174: 633-8 (Pubitemid 44395329)
62. Dales RE, Cakmak S, Judek S, et al. The role of fungal spores in thunderstorm asthma. Chest 2003; 123: 745-50 (Pubitemid 36315488)
63. Jarvie DR, Thompson AM, Dyson EH. Laboratory and clinical features of self-Poisoning with salbutamol and terbutaline. Clin Chim Acta 1987; 168: 313-22 (Pubitemid 17151326)
64. Rodrigo GJ, Rodrigo C. Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma. Emerg Med J 2005; 22: 404-8 (Pubitemid 40778989)
65. Elasayegh D, Shapiro JM. Management of the obstetric patient with status asthmaticus. J Intensive Care Med 2008; 23: 396-402
66. Selwyn Crawford J. Bronchospasm following ergometrine. Anaesthesia 1980; 35: 397-8
67. Bronchospasm during anaesthesia. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1988-1990. Chapter 9; 89-90
68. Rodrigo GJ, Rodrigo C, Pollack CV, Rowe B. Use of helium-oxygen mixtures in the 12: 820-827treatment of acute asthma. Chest 2003; 123: 891-6 (Pubitemid 36315508)
69. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: Potential benefits, limitations, and harm of clinical guidelines. Br Med J 1999; 318: 527-30 (Pubitemid 29189000)
70. Lee DL, Hsu CW, Lee H, Chang HW, Huang YC. Beneficial effects of albuterol therapy driven by heliox versus by oxygen in severe asthma exacerbation. Acad Emerg Med 2005; 12: 820-7 (Pubitemid 41191312)